• Episode 14: The Efficiency Trap
    Apr 17 2026

    First published in A Reasonable Rant: Private Edition (members-only subscription) on 19 Feb 2026.
    In this episode, Neo examines the venture studio model beyond its surface appeal. Drawing on a dataset of 406 studios and 1,843 startups across 45 countries, the analysis moves past portfolio optics to interrogate the system itself. Venture studios are designed to remove early-stage friction, accelerate launch, and improve survival rates. And on those terms, they work. But the data reveals a quieter tension: efficiency at the start does not translate into durability over time.

    As the episode unfolds, a pattern emerges. Success is highly concentrated, transition from studio to independent company remains fragile, and capital continues to follow the same power law seen in traditional venture. The issue is not that studios fail to create companies, but that they are optimised for beginnings rather than continuity. What looks like progress at the portfolio level often masks a deeper structural gap at the system level.

    This episode reframes the venture studio conversation entirely. Not as a question of whether the model works, but what it is actually designed to do and where that design stops. Because once you separate survival from endurance, the real question becomes unavoidable: are we building companies, or simply building more efficient ways to start them?

    Mehr anzeigen Weniger anzeigen
    23 Min.
  • Episode 13: Part 2- Notes from Zurich & What Global Innovation Gets Wrong
    Apr 11 2026

    First published in A Reasonable Rant: Private Edition (members-only subscription) on 12 Feb 2026.

    In Part 2 of this series, Neo moves beyond Davos as a coordination layer and tests its assumptions against reality. Drawing on over 27,000 funding records across eight continental zones and a structural review of more than 1,300 venture capital firms, this episode unpacks a harder truth: between 2020 and 2025, the world did not converge. It diverged. What appears as a global narrative is often a visibility illusion, shaped by uneven data, capital concentration, and incomplete maps of where innovation actually happens.

    This episode explores the deeper fractures beneath the surface. The sensor problem that distorts what we see. The stage gaps that prevent companies from scaling. The myth of a shared recovery. And the uncomfortable reality that capital does not fix systems, it amplifies them. What emerges is not a rejection of global coordination, but a clearer lens for reading it. Because once you see the map properly, the question changes: not whether innovation is growing, but where it holds, where it breaks, and why.

    Mehr anzeigen Weniger anzeigen
    20 Min.
  • Episode 12: The Davos Disconnect - Part 1
    Apr 6 2026

    First published in A Reasonable Rant: Private Edition (members-only subscription) on 5 Feb 2026.
    In this episode, Neo steps away from the spectacle and into the system behind it, unpacking how the World Economic Forum influences what becomes visible, credible, and ultimately fundable. Drawing from observations in Zurich during Forum week and Startup Spectra’s global dataset (2020–2025), this episode examines the hidden mechanics of legitimacy, the role of platforms like UpLink, and the growing gap between narrative and actual capital movement.

    What emerges is not a critique, but a structural insight. Davos does not deploy capital, it aligns it. And in doing so, it shapes how innovation is framed long before funding decisions are made. The problem is not whether the work matters. It’s whether it operates at a level that can meaningfully shift the system it sits inside.

    Mehr anzeigen Weniger anzeigen
    24 Min.
  • Episode 11: The Series-B Gap
    Mar 27 2026

    First published in A Reasonable Rant: Private Edition (members-only subscription) on 29 Jan 2026.

    In Episode 11, Neo unpacks one of venture capital’s least discussed pressure points: why so many companies that prove they can grow still fail to prove they can keep growing. This is not an episode about fundraising momentum or valuation milestones. It reframes Series B as a structural test, the point where startups stop being narratives about potential and become systems that must hold under real operational weight. Drawing on global venture data from 2020 to 2025, the episode shows that the sharp drop-off between Series B and Series C is not bad luck or founder failure, but a recurring pattern embedded in how companies are built and funded.

    The core issue is misalignment. Startups do not move through clean stages, yet capital behaves as if they do. By the time companies reach Series B, they are often carrying unresolved problems from earlier phases, validation gaps, fragile processes, and unclear decision structures, while being expected to operate like fully coordinated systems. Growth continues, but coherence breaks. Costs rise unevenly, teams expand faster than structure, and what once looked like momentum begins to strain under its own weight. Capital, instead of recalibrating the system, often responds with pressure, optimising for efficiency where redesign is needed, which amplifies the very weaknesses it is trying to fix.

    The episode ultimately reframes the Series B gap as a load-bearing failure in the venture model itself. It is not a shortage of capital, but a shortage of understanding and accommodation for what this stage actually demands. Geography sharpens the problem further, with emerging markets facing structural ceilings and misaligned expectations, while only a few ecosystems provide the depth of capital and patience required to absorb the transition. Series B is not a finish line. It is a crossing, and most companies are asked to carry more weight than they were ever designed to hold.

    Mehr anzeigen Weniger anzeigen
    25 Min.
  • Episode 10: The Gaming Paradox
    Mar 25 2026

    First published in A Reasonable Rant: Private Edition (members-only subscription) on 22 Jan 2026.
    In Episode 10, Neo examines one of tech’s most persistent contradictions: how an industry with billions of users, extreme daily engagement, and more revenue than film and music combined still struggles to produce durable venture-backed companies. This is not a discussion about consoles or visuals, but about gaming as an economic system that behaves more like infrastructure than software. Revenue did not collapse. Players did not disappear. What broke was investor belief that scale in gaming could reliably translate into venture-style outcomes.

    Using global funding data from 2020 to 2025 alongside firsthand experience building a national gaming operation in Central Africa, the episode shows how capital consistently miscategorised games as products rather than live social systems. Studios were funded to ship, not to operate. That mismatch becomes fatal in the space between Series B and Series C, where server costs, moderation risk, content pipelines, and community governance accelerate faster than capital can absorb. Fewer than half of gaming companies that reach Series B ever progress, not because the games fail, but because success creates operational weight most studios were never designed to carry.

    The episode closes by resolving the paradox. Gaming did not fail venture capital. Venture capital misunderstood gaming. The most resilient companies were not the loudest or best funded, but those built for continuity, not exits. They aligned with how players already behave, treated games as places people return to, and survived when venture belief collapsed. Gaming did not lack value. It was measured with the wrong ruler.

    Mehr anzeigen Weniger anzeigen
    21 Min.
  • Episode 9: Cybersecurity and the Identity Gap
    Jan 5 2026

    In Episode 9, Neo looks past breach headlines and shiny tools to examine cybersecurity as a system of incentives, decisions, and structural blind spots. The episode begins with a personal identity fracture that quickly spirals across borders, banks, telecoms, and compliance systems, exposing how fragile digital identity becomes once it stops behaving “normally”.

    Using an analysis of over 2,000 cybersecurity startups and more than 1,700 funding events between 2020 and 2025, representing roughly $74 billion in venture investment, the episode shows that this is not a story of underinvestment. It is a story of misalignment. Capital concentrated heavily around enterprise infrastructure and institutional buyers, while the everyday identity systems individuals rely on remained brittle, fragmented, and hard to recover when they fail.

    Neo unpacks the quiet drop-off between Series B and Series C, where many security companies stall not because their technology is weak, but because the economics of selling security collide with reality. The episode also challenges the growing reliance on “AI-powered” security as comfort rather than clarity, and explains why trust in cybersecurity still follows geography more than technical robustness.

    At its core, Episode 9 asks what security actually means in a world where systems protect organisations far better than people, and why the psychological cost of identity failure remains largely invisible, even as it quietly reshapes how we live and transact online.

    Mehr anzeigen Weniger anzeigen
    21 Min.
  • Episode 8: The Accelerator Paradox
    Jan 2 2026

    Are accelerators actually making companies better, or just making them easier to sell?

    In Episode 8, Neo digs into the uncomfortable gap between the accelerator myth and the post-demo-day reality. Drawing on first-hand experience designing and running programmes in sub-Saharan Africa, she traces how quickly “support” can turn into performance, and why polish is often mistaken for progress.

    Then the data lands the punchline. Between January 2024 and mid-2025, Neo analysed 879 funding rounds where an accelerator or incubator appeared as an investor, tracking who raised, who progressed, and who quietly disappeared once the spotlight moved on. The pattern is clear: accelerators show up in meaningful deal volume, but not in proportional capital intensity. In other words, they can improve early legibility without guaranteeing late-stage durability.

    This episode unpacks why the top 1–2% of programmes genuinely compound advantage, why most cannot, and how geography quietly tightens the funnel instead of widening it. You’ll hear why accelerators often compress the beginning but do not reliably solve the “middle” where unit economics, distribution, and operational resilience decide whether a business survives.

    If you are a founder choosing between credibility and capability, an investor treating “accelerator-backed” as a shortcut, or an ecosystem builder designing programmes with real outcomes, this rant is a practical reset: accelerators are not neutral tools, they shape behaviour. The question is whether they are shaping it towards building real companies, or towards fundraising theatre.

    Mehr anzeigen Weniger anzeigen
    24 Min.
  • Episode 7: When Biotech Needs a Grown-Up in the Room
    Dec 30 2025

    Biotech does not run on software timelines. You cannot sprint biology, you cannot “growth hack” regulation, and you definitely cannot ship a patch when the product is inside a human being.

    In this episode, Neo breaks down the uncomfortable mismatch between traditional venture capital’s speed instincts and biotech’s hard constraints, using fresh analysis of nearly 6,000 biotech and health-tech companies (almost 7,000 rounds, roughly $267B in announced investment) across 50+ countries from 2020 to 2025. Through a real investment decision inside a Chinese bone-regeneration startup, she shows why the biggest cheque is often the wrong choice, and why capability, manufacturing readiness, clinical access, and regulatory competence matter more than valuation optics.

    China becomes the case study for what happens when biotech is treated as industrial capability rather than a speculative side quest, and why corporate venture capital can be a load-bearing beam when the “long, uncomfortable middle” arrives. If you care about what gets to real patients, this episode is your reality check: in biotech, money is fuel, but infrastructure is the engine.

    Mehr anzeigen Weniger anzeigen
    24 Min.